Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAP | Q12884 | 5/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.32 |
| ▸ | NPY1R | P25929 | 3/20 | 0.32 |
| ▸ | NPY4R | P50391 | 3/20 | 0.32 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.32 |
| ▸ | NPY2R | P49146 | 1/20 | 0.32 |
| ▸ | GLP1R | P43220 | 7/20 | 0.31 |
| ▸ | SCTR | P47872 | 1/20 | 0.31 |
| ▸ | FURIN | P09958 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24864405 | 0.95 | FAP (0.40) | FAPNPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL29340481 | 0.94 | FAP (0.40) | FAPNPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL24864498 | 0.94 | FAP (0.40) | FAPGLP1R | |
| SCHEMBL24864507 | 0.93 | FAP (0.40) | FAPNPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL24864408 | 0.92 | FAP (0.40) | FAPGLP1RSCTRFURIN | |
| SCHEMBL24864380 | 0.92 | FAP (0.40) | FAPGLP1RFURIN | |
| SCHEMBL29346082 | 0.92 | FAP (0.40) | FAPGLP1RFURIN | |
| SCHEMBL24864625 | 0.91 | FAP (0.38) | FAPGLP1RSCTR | |
| SCHEMBL24864509 | 0.90 | NPY4R (0.37) | FAPNPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL29346068 | 0.89 | FAP (0.41) | FAPNPY5RNPY1RNPY4RMAP1LC3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151890-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-07-18 | — | — | WO | disclosed |